Hexane

Hexane

SCHEMBL721223

CCCCCC.O=S(=O)(O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Hexane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.59
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
TSHR P16473 1/20 0.50
THRB P10828 1/20 0.50
PPARA Q07869 2/20 0.48
FAAH O00519 2/20 0.48
CES2 O00748 4/20 0.47
CES1 P23141 4/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CA5A P35218 1/20 0.46
CA5B Q9Y2D0 1/20 0.46
EPHX1 P07099 2/20 0.46
AKR1B1 P15121 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nonane SCHEMBL10614203 0.96 TSHR (0.57) TP53CA1CA2TSHRTHRB
Tetradecane SCHEMBL272077 0.96 TSHR (0.57) TP53CA1CA2TSHRTHRB
Sulfuric Acid SCHEMBL1484174 0.96 TSHR (0.57) TP53CA1CA2TSHRTHRB
Heptane SCHEMBL8024410 0.96 TSHR (0.57) TP53CA1CA2TSHRTHRB
Decane SCHEMBL13586006 0.96 TSHR (0.57) TP53CA1CA2TSHRTHRB
Hexane SCHEMBL25306909 0.96 TP53 (0.56) TP53CA1CA2TSHRTHRB
Decane SCHEMBL13275986 0.96 TSHR (0.57) TP53CA1CA2TSHRTHRB
Dodecane SCHEMBL1939550 0.96 TSHR (0.57) TP53CA1CA2TSHRTHRB
Hexane SCHEMBL21802132 0.96 TP53 (0.56) TP53CA1CA2TSHRTHRB
Hexadecane SCHEMBL2541310 0.96 TSHR (0.57) TP53CA1CA2TSHRTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104557704-A Preparation method of pixantrone maleate BEIJING CHIRAL TECH PHARMACEUTICAL CO LTD 2015-04-29 CN claimed
CN-113646931-B Nonaqueous electrolyte for battery and lithium secondary battery 三井化学株式会社 2024-09-10 CN disclosed
CN-112444513-B Polycyclic aromatic hydrocarbon contaminated soil restoration effect evaluation method and detection kit 北京建工环境修复股份有限公司 2023-08-15 CN disclosed
CN-113045511-B Gemini dication Bronsted acid ionic liquid containing sulfonyl ring and preparation method thereof 华中科技大学 2023-03-31 CN disclosed
CN-112803067-B Electrolyte and lithium secondary battery comprising same 广州天赐高新材料股份有限公司 2023-02-24 CN disclosed
CN-111741980-B Heparin and heparan sulfate oligosaccharides 新加坡科技研究局 2023-02-17 CN disclosed
US-20220238909-A1 SECONDARY LITHIUM-ION BATTERY ELECTROLYTE SOLUTION FOR REDUCING BATTERY RESISTANCE AND SECONDARY LITHIUM-ION BATTERY THEREOF GUANGZHOU TINCI MATERIALS TECHNOLOGY CO., LTD. (CN) 2022-07-28 US disclosed
CN-110212235-B Lithium secondary battery electrolyte capable of reducing battery impedance and lithium secondary battery thereof 广州天赐高新材料股份有限公司 2022-04-08 CN disclosed
EP-3972024-A1 SECONDARY LITHIUM-ION BATTERY ELECTROLYTE FOR REDUCING BATTERY RESISTANCE AND SECONDARY LITHIUM-ION BATTERY THEREOF Guangzhou Tinci Materials Technology Co., Ltd. (CN) 2022-03-23 EP disclosed
CN-113785039-A Polypeptides having beta-glucanase activity, polynucleotides encoding same and use thereof in cleaning and detergent compositions 诺维信公司 2021-12-10 CN disclosed
WO-2011123732-A1 COMPOSITION COMPRISING MODIFIED ORGANOSILICONES THE PROCTER & GAMBLE COMPANY (US) 2011-10-06 WO disclosed
WO-2011123739-A1 COMPOSITIONS COMPRISING ORGANOSILICONES THE PROCTER & GAMBLE COMPANY (US) 2011-10-06 WO disclosed
US-20110243871-A1 ORGANOSILICONES THE PROCTER & GAMBLE COMPANY 2011-10-06 US disclosed
US-20110243875-A1 CARE POLYMERS THE PROCTER & GAMBLE COMPANY 2011-10-06 US disclosed
EP-1765849-A4 PROCESS FOR PROTEIN ISOLATION AVT PLASMA LTD (AU) 2007-09-05 EP disclosed
EP-1765849-A1 PROCESS FOR PROTEIN ISOLATION AVT Plasma Limited (AU) 2007-03-28 EP disclosed
WO-2005121165-A1 PROCESS FOR PROTEIN ISOLATION AVT PLASMA LIMITED (AU) 2005-12-22 WO disclosed
US-4485828-A Use of substituted methyl isopropyl cyclohexenones in augmenting or enhancing the aroma or taste of smoking tobacco compositions and smoking tobacco article components INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1984-12-04 US disclosed
US-4449008-A FROM ISOBUTYRALDEHYDE AND ACETONE OR METHYL ETHYL KETONE INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1984-05-15 US disclosed
US-4400311-A Substituted methyl isopropyl cyclohexenones, organoleptic uses thereof and process for preparing same INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1983-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243871-A1 ORGANOSILICONES NISCH, XRCC6, RAD50 TP53 413/4885CA1 3544/4885CA2 4431/4885
US-20110243875-A1 CARE POLYMERS SMURF1, PUF60, PCBP1 TP53 1325/4885CA1 3923/4885CA2 4657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.